New hope for severe eczema: safer drug challenge
NCT ID NCT00809172
Summary
This study tested whether methotrexate works as well as cyclosporine for adults with moderate-to-severe eczema (atopic dermatitis). Both drugs aim to control the disease, but cyclosporine carries risks like high blood pressure and kidney problems. Researchers enrolled 100 patients to see if methotrexate could be a safer, equally effective option over 24 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospices Civils de Lyon
Lyon, France
Conditions
Explore the condition pages connected to this study.